Timing of brain metastases in relation to outcome during first-line ipilimumab plus nivolumab therapy for metastatic melanoma in a community oncology practice - Poll - MDSpire

Timing of brain metastases in relation to outcome during first-line ipilimumab plus nivolumab therapy for metastatic melanoma in a community oncology practice

  • By

  • Claire Victoria Ong

  • Wolfram Samlowski

  • February 11, 2025

  • 0 min

Share

Original Source(s)

Timing of brain metastases in relation to outcome during first-line ipilimumab plus nivolumab therapy for metastatic melanoma in a community oncology practice

  • by Claire Victoria Ong, Wolfram Samlowski

  • February 11, 2025

Related Content

Impact of thrombosis on disease progression, cancer and mortality in patients with essential thrombocythemia and polycythemia vera

Errors in the Table 2

  • May 1, 2026

Clinical GBM hybrid artificial intelligence for prescription dose recommendation and outcome prediction after gamma knife radiosurgery treatment: a proof-of-concept